The case for reducing US equity overweight: Concentration, valuation, and the coming regime shift



Share

Executive Summary

Global equity portfolios are more concentrated in US stocks than at almost any point in history. The US now accounts for roughly 65 percent of the MSCI All Country World Index, a weight that has roughly doubled since the early 1990s and is more than four times its share of global GDP. This is not simply a reflection of American economic strength. It is also a structural artefact of passive investing, where rising prices inflate index weights, which attract further inflows, which push prices higher still. This can create a self-reinforcing cycle which leaves many investors overlooking the US overweight.

The case for reducing this concentration rests on several independent lines of evidence that converge on the same conclusion. US equity valuations sit at a substantial premium to the rest of the world, and to their own history, at levels that imply an earnings growth differential with no reliable historical precedent. A well-established empirical regularity shows that starting valuations have some predictive power over long-run returns. Investors buying at today’s US multiples are therefore accepting lower forward returns, whether they realise it or not. At the same time, the geopolitical calculus has inverted. US equities were once the safe core of a global portfolio but policy volatility, trade fragmentation, and institutional strain have become domestic American phenomena. Meanwhile the dollar’s structural advantage, the “exorbitant privilege” that compresses US borrowing costs and inflates asset valuations, is quietly eroding, as reserve managers from Beijing to Tokyo reduce their holdings of dollar assets in favour of gold and real assets. Formal welfare analysis using a calibrated international general equilibrium model reinforces the same point, that rising trade costs reduce the insurance value of US equity holdings, and the scale of tariff increases since early 2025 is sufficient, on its own, to justify a material reduction in US portfolio weight.

The prescription is not dramatic rotation. Abandoning US equities for the rest of the world confuses a rebalancing thesis with a directional macro call. Instead, the appropriate response is more measured. A gradual reduction in US overweight, directed toward markets where the valuation case is clearest, including the UK and selective parts of continental Europe and emerging markets. History suggests this kind of adjustment is made in one of two ways: deliberately and early at a modest cost, or reactively and late after the repricing has already occurred. The cost of being early is modest tracking error. The cost of being late is losing the adjustment, even if its precise timing is unknowable in advance.

read full article

This content is provided for informational purposes and is directed to clients and eligible counterparties as defined in Directive 2011/61/EU (AIFMD) and Directive 2014/65/EU (MiFID II) Annex II Section I or Section II or an investor with an equivalent status as defined by your local jurisdiction.  Fulcrum Asset Management LLP (“Fulcrum”) does not produce independent Investment Research and any content disseminated is not prepared in accordance with legal requirements designed to promote the independence of investment research and as such should be deemed as marketing communications.  This document is also considered to be a minor non-monetary (‘MNMB’) benefit under Directive 2014/65/EU on Markets in Financial Instruments Directive (‘MiFID II’) which transposed into UK domestic law under the Financial Services and Markets Act 2000 (as amended). Fulcrum defines MNMBs as documentation relating to a financial instrument or an investment service which is generic in nature and may be simultaneously made available to any investment firm wishing to receive it or to the general public. The following information may have been disseminated in conferences, seminars and other training events on the benefits and features of a specific financial instrument or an investment service provided by Fulcrum.

Any views and opinions expressed are for informational and/or similarly educational purposes only and are a reflection of the author’s best judgment, based upon information available at the time obtained from sources believed to be reliable and providing information in good faith, but no responsibility is accepted for any errors or omissions. Charts and graphs provided herein are for illustrative purposes only. The information contained herein is only as current as of the date indicated, and may be superseded by subsequent market events or for other reasons. Some of the statements may be forward-looking statements or statements of future expectations based on the currently available information. Accordingly, such statements are subject to risks and uncertainties. For example, factors such as the development of macroeconomic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. In no case whatsoever will Fulcrum be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages. Reproduction of this material in whole or in part is strictly prohibited without prior written permission of Fulcrum Copyright © Fulcrum Asset Management LLP 2026. All rights reserved.

FC1761 210426


If you are interested in receiving regular updates on our funds specifically, please visit our Fund Centre to sign up directly.